BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Clinical trial NCT04673955 · RECRUITING
Trial details
- NCT number
- NCT04673955
- Sponsor
- Pierre Fabre Pharma GmbH
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-03
- Primary completion
- 2026-09-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.